References
- Zafar SY, Peppercorn JM, Schrag D, Taylor DH, et al. The financial toxicity of cancer treatment: A pilot study assessing out–of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381–390.
- Ramey S, Blough D, Kirchoff A, Kreizenbeck K, et al. Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Affairs. 2013;32(6):1143–1152.
- Pollitz K, Cox C, Lucia K, Keith K. Medical Debt among People with Health Insurance: A Report from the Kaiser Family Foundation; January 2014. Available online at http://kff.org/private-insurance/report/medical-debt-among-people-with-health-insurance. Last accessed July 9, 2014.
- The Advisory Board Company. Addressing Patient's Financial Obligations: Best Practices for Optimizing Collections and Supporting Patients with Need; 2009. Restricted content. Available online to Advisory Board Members at: www.advisory.com.
- Community Oncology Alliance. Americans fear paying for cancer treatments as much as dying of the disease. Oncol Times; 2009;31(15):16–17.
- Stump TK, Eghan N, Efleston BL, et al. Cost concerns of patients with cancer. J Oncol Practice. 2013; 9(5):251–257.
- Mosely WG, Nystrom JS. Dispensing oral medications: Why now and how? Community Oncol. 2009; 6(8):358–361.
- Abboud C, Berman E, Cohen A, Cortes J, et al. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: From the perspective of a large group of CML experts. Blood. 2013; 121(22):4439–4442.
- Avalere Health. Oral Oncolytics: Addressing the Barriers to Access and Identifying Areas of Engagement. Community Oncology Alliance Report, 2010. Available online at: www.communityoncology.org/pdfs/avalere-coa-oral-oncolytics-study-summary-report.pdf. Last accessed July 9, 2014.
- Chino F, Peppercorn J, Taylor DH, Lu Y, et al. Self-Reported Financial Burden and Satisfaction with Care Among Patients With Cancer. Oncologist. 2014; 19(4):414–420.